AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Shiglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Mediarka Lifesciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Shiglim M 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continued use is crucial, even with well-controlled blood sugar; abrupt cessation can lead to dangerously elevated glucose levels, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect of Diabex Duo. Learn to identify symptoms like sweating, lightheadedness, headache, and tremors, and know how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment, as it may not be appropriate. Pregnant or lactating women should seek medical counsel before use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Shiglim M 2mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rewrite.

Uses of Shiglim M 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Shiglim M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Shiglim M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Shiglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Shiglim M 2mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Shiglim M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Shiglim M 2mg/500mg Tablet SR works:

Shiglim M SR tablets (2mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Shiglim M 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Shiglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Shiglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Shiglim M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. Shiglim M 2mg/500mg SR tablets are contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Caution is advised when prescribing Shiglim M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is recommended. For patients experiencing mild to moderate liver dysfunction, initiation should involve a reduced Shiglim M 2mg/500mg SR tablet dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Shiglim M 2mg/500mg Tablet SR :

Should you forget a Shiglim M 2mg/500mg SR Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Shiglim M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Shiglim M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Shiglim M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these symptoms, discontinue Shiglim M and seek immediate medical attention.
Shiglim M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Shiglim M 2mg/500mg SR tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Shiglim M 2mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Shiglim M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Shiglim M 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Shiglim M 2mg/500mg Table...
56
MRP 65
13% off